• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACCESS BIO INCORPORATE CARESTART COVID-19 ANTIGEN HOME TEST; COVID-19 ANTIGEN SELF-TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACCESS BIO INCORPORATE CARESTART COVID-19 ANTIGEN HOME TEST; COVID-19 ANTIGEN SELF-TEST Back to Search Results
Model Number N/A
Device Problem Unraveled Material (1664)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/18/2023
Event Type  malfunction  
Manufacturer Narrative
In order to identify the true root casuse of this allegation, access bio would need to further communicate with the complainant to rule out potential root causes.However, in the absence of information from the customer it would be difficult to rule out potential root causes identified below.1.Complainant might misinterpret test result 2.Complainant might not follow the instructions for use (ifu) a.Inadequate sample collection b.Interpreting results before 10 minutes c.Not performing test immediately after opening the test device in the pouch d.Potential contact with foreign substances and household cleaning products during sample collection and testing.E.Operating test outsdie of storage conditions f.Excessive buffer application to sample well of test device 3.Complainant might not use the test in accordance with its intended use a.Taking high doses of biotin (>10 mg per day) 4.13% of false negative results are expected based on perfromance characteristics claimed for this test (87% ppa) 5.Tests might be exposed to extreme environmental conitions during storage 6.Rapid test that she performed might yield false negative result access bio will continue to monitor further complaints through our data trending programs and take further actions based on identified valid trends.
 
Event Description
On (b)(6) 2023, accessbio received a complaint from an email regarding false negative.The complainant tested on care start product on (b)(6) 2023 & on (b)(6) 2023 and tested negative; however, coronavirus antigen ia rapid test performed 1 hour after on (b)(6)2023 came up positive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARESTART COVID-19 ANTIGEN HOME TEST
Type of Device
COVID-19 ANTIGEN SELF-TEST
Manufacturer (Section D)
ACCESS BIO INCORPORATE
65 clyde rd suite a
somerset NJ 08873
Manufacturer Contact
howard luu
65 clyde road, suite a
somerset, NJ 08873
7328734040
MDR Report Key18558136
MDR Text Key333464257
Report Number3003966368-2023-00143
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210314
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/01/2024
Device Model NumberN/A
Device Catalogue NumberRCPM-00271
Device Lot NumberCP22L06
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
Patient EthnicityNon Hispanic
-
-